Excellent short‐term survival after pediatric liver transplantation (LT) has shifted attention toward the optimization of long‐term outcomes. Despite considerable progress in imaging and other noninvasive modalities, liver biopsies continue to… Click to show full abstract
Excellent short‐term survival after pediatric liver transplantation (LT) has shifted attention toward the optimization of long‐term outcomes. Despite considerable progress in imaging and other noninvasive modalities, liver biopsies continue to be required to monitor allograft health and to titrate immunosuppression. However, a standardized approach to the detailed assessment of long‐term graft histology is currently lacking. The aim of this study was to formulate a list of histopathological features relevant for the assessment of long‐surviving liver allograft health and to develop an approach for assessing the presence and severity of these features in a standardized manner. Whole‐slide digital images from 31 biopsies obtained ≥4 years after transplantation to determine eligibility for an immunosuppression withdrawal trial were selected to illustrate a range of typical histopathological findings seen in children with clinically stable grafts, including those associated with alloantibodies. Fifty histological features were independently assessed and, where appropriate, scored semiquantitatively by six pathologists to determine inter‐ and intraobserver reproducibility of the histopathological features using unweighted and weighted kappa statistics; the latter metric enabled distinction between minor and major disagreements in parameter severity scoring. Weighted interobserver kappa statistics showed a high level of agreement for various parameters of inflammation, interface activity, fibrosis, and microvascular injury. Intraobserver agreement for these features was even more substantial. The results of this study will help to standardize the assessment of biopsies from long‐surviving liver allografts, aid the recognition of important histological features, and facilitate international comparisons and clinical trials aiming to improve outcomes for children undergoing LT.
               
Click one of the above tabs to view related content.